2024 PHARM Connect Congress Catalogue for Public

“Discovery consists of seeing what everyone has seen and thinking what nobody has thought”

Albert Szent-Györgyi (1893-1986), Biochemist & Nobel Prize Winner for Medicine in 1937

PARTNERS OF PHARM CONNECT 2024

The Events Group (TEG) is one of Europe’s leading business information providers. With two main services, business-to-business congresses, and professional trainings, we primarily focus on the key emerging markets in Central & Eastern Europe.

Our unique business-to-business congresses bring together senior-level executives from Europe’s largest organisations with a select and diverse group of cutting-edge suppliers. Strictly operating on an invitation-only basis guarantees the highest level of delegate is present.

Welcome

...

TO THE PHARM CONNECT CONGRESS 2024!

On behalf of TEG, we welcome you to the annual PHARM Connect Congress 2024, one of the largest pharmaceutical and biotechnology manufacturing events and the only regional one for Central and Eastern Europe in 2024.

The quality of the Congress is a direct result of its exclusivity. We have worked closely together with our programme advisory committee, leading local and regional associations and well-respected European and international media partners to ensure the event is of the highest quality and to guarantee its regional scope.

The Congress has been tailor-made for senior industry professionals to provide them with a platform which offers the most up-to-date market insights into R&D, production, engineering, logistics, purchasing and quality management-related topics along with innovative product and service presentations offered by leading local and international solution providers.

We are confident that our focused and targeted congress model will be a catalyst for your business success in one of the fastest-growing European regions in the pharmaceutical and biotechnology industries. Furthermore, we trust the PHARM Connect Congress will offer you the ideal networking opportunity to catch up on the latest developments and trends in your industry.

The TEG team wishes you a rewarding and fulfilling two days at the PHARM Connect Congress 2024 in Budapest and we look forward to seeing you again at future TEG events.

Dennis Lantos Managing Director The Events Group

Katy Säurich Head of Operations & Production The Events Group

1

BALLROOM TERRACE

GRAND BUDAPEST BALLROOM EXHIBITION

REGISTRATION

COFFEE LOUNGE & COCKTAIL RECEPTION

BUDAPEST MARRIOTT HOTEL

CLOAKROOM

CONFERENCE ROOM

HOTEL RESTAURANT & LUNCH AREA ON GROUND FLOOR

HOTEL LOBBY & GROUND FLOOR

HOTEL LOBBY & GROUND FLOOR

GRAND BUDAPEST BALLROOM – EXHIBITION, 1 ST FLOOR

GRAND BUDAPEST BALLROOM – EXHIBITION, 1 ST FLOOR GROUND FLOOR

LIST OF VENDORS

1. ZETA GMBH

2. PLASTRADE PACKAGING

3. ROCHE CUSTOMBIOTECH

4. EFAFLEX HUNGÁRIA LTD.

5. EFA GLOBAL DOCKING LTD.

6. EFA SERVICES HUNGARY LTD.

7. FETTE COMPACTING GMBH

8. JBT

9. VIMACHEM

10. WIPOTEC GMBH

11. ITALVACUUM

12. TISZATEXTIL PACKAGING SAS

13. HAMILTON BONADUZ AG

14. RAUMEDIC AG

08:30

DAY 1 | TUESDAY, MARCH 5 TH

09:30-09:40

Doors open and event registration begins

TEG WELCOME ADDRESS:

Katy Säurich, Head of Production & Operations, TEG The Events Group

CHAIRMAN’S OPENING ADDRESS:

Dr. Louis Boon, CSO & Management Board Member, JJP Biologics & Principal Scientific Advisor, Polpharma Biologics

KEYNOTE OPENING PRESENTATION: The Future for Microbial Fermentation Based Products

• What are the key differences between microbial and mammalian cell fermentation products?

09:40-10:20

• What are the key technology differences between these platforms

• What is the range of biopharmaceuticals that can be manufactured through microbial fermentation

• Opportunities and threats

Dr. Erik Bogsch, Head of the Biotechnology R&D Division, Gedeon Richter

10:20-10:40

Networking and Vendor Viewing

CASE-STUDY PRESENTATIONS FOLLOWED BY A Q&A SESSION: Business Development: How to do it Right from a Small and Mid-sized Biotech Company Perspective

• Main reasons for initiating business development and partnering activities

• Challenges in running business development activities efficiently

10:40-11:20

11:20-11:40

• Most frequent mistakes made

• How to do it right?

Paweł Szczepański, COO & Board Member, JJP Biologics

Iván Jákó, Senior Business Development Manager, Gedeon Richter

Networking and Vendor Viewing

5-6 March 2024 | www.pharmconnect.eu

11:40-12:20

CASE-STUDY PRESENTATION: New Approach to Antibacterial Therapy: Development of bacteriophage-containing Formulations for Human Use

• In the European Union, 670,000 people are infected with antibiotic-resistant bacteria every year, 33,000 of whom die.

• This number is projected to increase tenfold by 2050. The WHO and EMA are working hard to tackle the problem, and one of the most promising tools is the use of phage therapy.

• FLUART Innovative Vaccines Ltd. started developing this technology a few years ago.

• The aim of our presentation is to describe the R&D and scale-up experiences and opportunities with this technology.

Balázs Kiss, R&D Director, FLUART Innovative Vaccines

12:20-13:20

Lunch in the Restaurant on the Ground Floor of the Hotel

13:20-13:40

Networking and Vendor Viewing

CASE-STUDY PRESENTATION: Benefits and Pitfalls in Implementation and Application of Machine Learning Methods in Biologics Discovery

• Data curation

13:40-14:20

• Model development

• Orchestration of models

• Staying on top of science

Paweł Dudzic, Senior Data Engineer, NaturalAntibody

14:20-14:40

Networking and Vendor Viewing

CASE-STUDY PRESENTATION: AADvac1 lead active tau immunotherapy program for treatment and secondary prevention of Alzheimer’s Disease: Recent Phase 2 results

• AADvac1 is the first-in-man, first-in-kind active tau immunotherapy, stimulating the immune system to produce antibodies specific for all pathological forms of tau;

14:40-15:20

• The completed Phase II study has previously demonstrated an exceptional safety profile of the vaccine and an effect on several plasma and CSF biomarkers (Novak et al, Nature Aging 2021)

• The recent post-hoc analysis has revealed significant treatment effects in biomarkerconfirmed AD patients on cognitive, functional and neurodegeneration-related biomarker endpoints. The response to treatment was directly related to the levels of AADvac1-induced anti-tau antibodies.

Dr. Branislav Kovacech, Deputy CSO, AXON Neuroscience

15:20-15:40 Networking and Vendor Viewing

15:40-16:20

5-6 March

CASE-STUDY PRESENTATION: Development of Biosimilars: From Streamlined Development to Increased Access to Affordable Biologicals

• Streamlining biosimilar development: do we really need biosimilar efficacy trials?

• Real-world evidence for biosimilars: impact on interchangeability

• Policy impact on sustainability of the biosimilar market

• Influence of biosimilar competition on access to affordable biologicals

Dr. Zsolt Holló, Alliance Management Head, Polpharma Biologics

16:30 Cocktail Reception in the Foyer of the Budapest Ballroom

5-6 March 2024

DAY 2 | WEDNESDAY, MARCH 6 TH

08:30 Door opening

09:30-09:40

09:40-10:20

CHAIRPERSON’S OPENING ADDRESS:

Dr. Mahwash Mukhtar, Research Fellow at the Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged

CASE-STUDY PRESENTATION:

Implementation of eBatch Record System - Lessons learnt

• Project summary

• Why to do it - Pro’s and Con’s

• GMP implications

• Do’s and Don’t

• Conclusions

István Király, Site Director of Körmend, EGIS Pharmaceuticals

10:20-10:40 Networking and Vendor Viewing

CASE-STUDY PRESENTATION: Understanding the Manufacturing Process – From Development to Ongoing Verification

• Manufacturing process development – establishing control strategies for CPPs

• Do the same control strategies apply for process validation and ongoing verification?

10:40-11:20

• Bringing ongoing process verification into life

• Two years later and after Regulatory inspection

Ivana Kovač Lovrenčić, Head of R&D Pharmaceutical Technology Department & Small-Scale GMP Solid Dosage Forms Manufacturing & Lenka Francišković, Head of Processes and Products Quality, Belupo

11:20-11:40 Networking and Vendor Viewing

CASE-STUDY PRESENTATION: Cooperation between Quality and Production as a Road to Success in the Pharmaceutical World

• What Production and Quality can learn from each other?

11:40-12:20

• Necessary areas of cooperation

• The right way of thinking, openness, transparency and respect as the path to success

Dr. Piotr Lipiński, Global Quality Auditor GMP, Sandoz

12:20-13:20 Lunch in the Restaurant on the Ground Floor of the Hotel

13:20-13:40 Networking and Vendor Viewing

CASE-STUDY PRESENTATION:

Risk Management and Business Continuity in ALKALOID Skopje

13:40-14:20

Nada Popstefanova, Quality Compliance and Audit/ Inspection Readiness Manager, ALKALOID Skopje

Sonja Spirovska Burcevska, Ecology Coordinator, ALKALOID Skopje

Verce Jovanovska Jankovska, Qualified Person, ALKALOID Skopje

14:20-14:40 Networking and Vendor Viewing

PANEL DISCUSSION:

Overcoming Supply Chain Challenges in Pharma Manufacturing

• Overcoming challenges regarding raw materials supply and increased lead time

• Re-shoring to Europe and chances for CEE

14:40-15:20

15:20-15:30

• New approaches to planning and controlling supply chains and their resilience

Erika Dobos, Supply Chain Director, Kedrion Biopharma

István Király, Site Director of Körmend, EGIS Pharmaceuticals

Dr. Piotr Lipiński, Global Quality Auditor GMP, Sandoz

CHAIRPERSON’S CLOSING REMARKS:

Dr. Mahwash Mukhtar, Research Fellow at the Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged

DAY 1 | CHAIRMAN

Dr. Louis Boon

CSO & Management Board

Member,  JJP Biologics and Principal Scientific Advisor, Polpharma Biologics

Louis is the CSO and Management Board

Member of JJP Biologics, an innovative new Polish company backed by the Starak family. JJP Biologics develops the next generation of novel therapeutic biologics around personalized medicine and companion diagnostics. Louis obtained his Ph.D. in Biochemistry at the University of Amsterdam. He was the founder of various companies focused on the generation and development of therapeutic monoclonal antibodies, primarily in the field of cancer and inflammation. In 2003, he was one of the founders of Bioceros BV, now Polpharma Biologics, where he currently holds the position of Principal Scientific Advisor. In addition, he held positions as CSO at MacroZyme BV, 4AZA Bioscience NV, FF Pharma, and VP preclinical for PanGenetics BV and Tanox. Louis is an author of over 340 publications in international scientific journals in the field of medical biotechnology and an inventor at more than 20 patent applications.

DAY 2 | CHAIRPERSON

Dr. Mahwash

Mukhtar

Research Fellow at the Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged

Dr. Mahwash Mukhtar is currently a Research fellow at the Institute of Pharmaceutical Technology and Regulatory Affairs at the University of Szeged (Hungary). She acquired her Ph.D. in Pharmaceutical Technology from the University of Szeged in 2022. She has previously been working as a principal scientist in different Hungarian, Hungarian-Croatian, and Hungarian-Pakistani bilateral projects, along with a visiting researcher in CiMUS, University of Santiago de Compostella (Spain).

Her areas of expertise include macrophagetargeted drug delivery in inflammatory disorders, pulmonary dry powder nanomedicines, anti-biofilm coating of 3D printed catheters, oral nano-mediated drug delivery, and in-vivo studies. Moreover, she is also working on the chemical derivatization of biocompatible polymers to improve therapeutic outcomes, especially in dealing with antibiotic and antimicrobial resistance.

Her educational and research achievements have been recognized by the Higher Education Commission, Pakistan. She has won many grants such as Stipendium Hungaricum, International travel fellowships, and an honorary Master’s degree in Science from the University of Lahore (Pakistan). Her research has been published in high-ranked journals; she is also an active member of the Aerosol Society (UK), Pakistan Pharmacists’ Association, and American Chemical Society and is serving as an editor in highly esteemed journals.

PRESENTERS

Dr. Erik Bogsch

Head of the Biotechnology R&D Division, Gedeon Richter

Dr Erik Bogsch is the Head of the Biotechnology R&D Division at Gedeon Richter Plc. He is responsible for leading the R&D effort in the development of GR’s biosimilar pipeline. Gedeon Richter Plc. is engaged in the development and manufacture of both bacterial cell fermentation based and mammalian cell fermentation based biosimilar products. GR has R&D, analytical & manufacturing capabilities in multiple locations in Hungary & Germany.

Dr Bogsch, a Hungarian national, has a Natural Sciences degree from the University of Cambridge and a PhD in cell biology from the University of Warwick. Following a brief postdoctoral academic research career, he worked in the food industry for many years in R&D, Quality & Manufacturing roles in the UK, Hungary & Germany. He joined Gedeon Richter Plc. in 2012, as commissioning lead for GR’s biotechnology factory in Debrecen, Hungary, before moving into his current role.

István Király graduated from the Technical University in Budapest as a mechanical engineer. During his professional career he has filled several technical- and production-related management positions in different industries at large international companies such as General Electric, DANONE, Alcoa and GlaxoSmithKline. These challenges allowed him to be involved in the implementation and operation of different management and quality systems such as ISO, HACCP, GMP, Toyota Production System, Six Sigma and Lean Sigma.

In 2006 he joined GSK Vaccines and started his career in Gödöllő Manufacturing site. He held various senior management positions until he was appointed as Managing director of the site in 2011. In 2015 he was nominated to VP, Head of Operations of the legacy Novartis Vaccines sites, overseeing the industrial operations of those sites and also managing the integration of those newly acquired manufacturing units into GSK Vaccines industrial network. In 2016 he was promoted to VP, Site Director Siena & Rosia Operations, Italy at GSK Vaccines.

In 2018 István returned to Hungary, and joined HUMAN BioPlazma (part of Kedrion Group) as Site Director, were he was accountable for the entire operations of the Hungarian Subsidiary of Kedrion Biopharma.

Since 2022 István is the Site Director at Egis Pharmaceutical responsible for the Körmend site.

Site Director Körmend, EGIS Pharmaceuticals

István Király

Ivana Kovač Lovrenčić

Head of R&D Pharmaceutical Technology Department & SmallScale GMP Solid Dosage Forms Manufacturing, Belupo

Ivana Kovač Lovrenčić, M.Pharm. has been in Belupo Inc. since 2006, primarily working in R&D on formulation and process development, technology transfer and CTD Module 3 preparation for small molecule solid, semisolid and liquid dosage forms. Through the years she has gained broad experience working on different projects related to inhouse development, contractual development, regulatory applications, process improvement and procurement and qualification of manufacturing equipment. She has also acquired advanced knowledge on GMP and ISO guideline implementation as a representative of small-scale solid dosage forms production. As a department head, she leads a small team of technicians and technologist dedicated to technological development of new generic products together with manufacture of smallscale commercial batches.

After work, Ivana enjoys doing DIY projects, travelling and spending active time in nature. She volunteers in a project for empowering young girls between 12 and 18 years of age.

Lenka Francišković

Head of Processes and Products Quality, Belupo

Lenka is a Pharmaceutical Professional with a unique combination of pharmaceutical management experience and exceptional knowledge in the areas of the New Product Evaluation, Laboratory Operations, Pharmaceutical Analysis and Project Management. She has an extensive experience in pharmaceutical industry in Research and Development, Regulatory Affairs, Quality Assurance and Quality Control Environment as well as profound knowledge of TPB and FDA, EU and Croatian regulatory submission requirements.

Strong knowledge of GMP, GLP, ICH guidelines and Pharmacopoeia is inevitable part of Lenkas‘ professional skills. Lenka is currently Head of Processes and Products Quality for Belupo Pharmaceuticals Croatia. Prior to this work, she worked in several positions at Apotex Inc. Toronto, Ontario and Genpharm Inc. (now Milan Pharmaceuticals) in Etobicoke, Ontario. Lenka has published several publications, is member of Pharmaceutical Sciences Group, Toronto and Croatian Association for Quality.

Dr. Piotr Lipiński

Global Quality Auditor, GMP, Sandoz

Piotr has over 12 years of experience in pharmaceutical companies. Currently, he is a Global Quality Auditor in Sandoz, before he worked in pharmaceutical manufacturing sites as Quality Assurance Specialist, Qualified Person and Quality Systems Manager. The experience includes particularly quality systems implementation, self-inspections, training and auditing of materials, products suppliers and service providers. Piotr has detailed knowledge in the scope of all GxP rules with a special focus on Good Manufacturing Practice and Good Distribution Practice.

Piotr is a PhD Eng. in the scope of Technology of Chemistry. Additionally, he completed postgraduate studies in the scope of Industrial Chemistry at the Medical University of Gdansk. He was participating as well in numerous courses related to GMP aspects in the pharmaceutical industry.

Paweł Szczepański

COO, Management Board Member, JJP Biologics

Paweł is the COO and Management Board Member of JJP Biologics. Involved in the biopharmaceutical market since 2014 as Supervisory Board Member of Polpharma Biologics Warsaw. Paweł has built experience in the pharmaceutical industry since 2010. First in a pharma-specialized advisory and market research house and subsequently in various capacities in Polpharma, including Director of Corporate Project Office. Prior to that has worked for six years in investment banking and management consulting in Portugal and Poland. Paweł also serves as a Supervisory Board member of Herbapol Lublin. Paweł graduated from the Warsaw School of Economics (MSc) and holds a master’s degree in law from the Warsaw University.

Paweł Dudzic

Senior Data Engineer, NaturalAntibody

Paweł Dudzic brings more than 12 years of software engineering expertise, with a specialized focus on database development, to his current role at NaturalAntibody. With nearly three years dedicated to creating biological databases essential for drug discovery, he now focuses on developing databases and bioinformatics software specifically aimed at analyzing antibody sequences. His work at NaturalAntibody seamlessly merges technology with biology, pushing the boundaries of scientific research forward.

Erika Dobos

Supply Chain Director, Kedrion Biopharma

Erika Dobos has more than 25 years of experience in Supply Chain. In addition to her master’s degree in logistics management, she also obtained the diploma in procurement management and the diploma in Lean Process development specialist.

Erika started her professional career at the Hungarian factory of B.Braun before joining Kedrion in 2020. In her previous position, she was responsible for logistics, purchasing and production planning.

Erika’s current responsibilities include logistics and procurement. Including supplier selection, contract negotiation and supplier risk mitigation. In the current changing environment, this is the most challenging task for all organizations. She believes that the supply chain is the profession that must constantly work to adapt to environmental changes. You can’t be bored in this area!

Iván Jákó

Senior Business Development Manager, Gedeon Richter

Iván Jákó has been a Senior Business Development Manager at Gedeon Richter since 2018, being responsible for licensing-out activities, the management of various aspects of the partnering process regarding biosimilar products for countries where Gedeon Richter would not commercialize these products via own subsidiaries. His tasks include the search for partners, coordination of business assessments and due diligence processes, negotiation of contracts and post-deal alliance management.

Furthermore, Iván also supports the CDMO services offered by Gedeon Richter in the field of biotechnology, by managing general business development activities, preparation and negotiation of proposals, contracting as well as client management.

Before joining Gedeon Richter he held several management positions such as Managing Director at DayMed, Marketing Manager Rx & OTC at Berlin-Chemie/A. Menarini Hungary, Marketing Manager Rx at Boehringer Ingelheim Hungary, and Leader of Generics Project at Biogal Rt. / TEVA Hungary.

In his leisure time, Iván enjoys flying, cycling, trekking, and active travelling to exotic places in the world.

Zsolt Holló

MD, PhD, MBA, PMP, Alliance Management Head, Polpharma Biologics

Zsolt Hollo is a medical doctor by training, holding various other degrees and qualifications. He is a biosimilar expert, active in this field for 14 years.

He is one of the founding scientists of Solvo Biotechnology (a Charles River Company), a pioneering biotechnology company in the drug transporter / ADME-Tox field. He was Medical Director and Chief Operations Officer at Solvo Biotechnology from 2004 to 2009.

He worked at EGIS Pharmaceuticals in 2010-2023. As the Head of the Center of Biotechnology Business Development and Technology, he was responsible for various biosimilar related projects (technology transfer, setting up an EU release testing laboratory, alliance management with a strategic biosimilar manufacturer, due diligence of biosimilar products) and various other R&D projects in chronic inflammatory diseases.

He joined Polpharma Biologics in November 2023 as alliance management head.

Balázs has 20 years of experience in the biopharmaceutical industry including Process technology, Regulatory and cGMP compliance for biotechnology. He has extent knowledge of novel technologies such as therapeutical proteins, vaccines, drug substance, drug product, which ensures him a complete understanding of all issues associated with red biotechnology.

Balázs has an impressive experience across all areas of the biopharmaceutical industry encompassing R&D and production processes and facilities for human biopharmaceuticals, vaccines, therapeutic proteins, plasma derivatives, radiopharmacons from drug substance to final drug product.

Branislav Kováčech, Ph.D., joined Axon Neuroscience in 2002 as a research scientist to identify therapeutic targets for Alzheimer’s disease. He was part of the core team who developed immunotherapies for the disease, co-authoring several patents. As the head of Pharmacology, he supported the development of manufacturing processes and analytics for the lead vaccine. Branislav has actively participated in clinical development, the design of the clinical trial protocol, bioanalytical methods, and data interpretation, authoring several publications in high-impact journals as a result. Currently, he serves as a deputy CSO.

R&D Director, FLUART Innovative Vaccines

Balázs Kiss

Head of Pharmacology & Deputy CSO, AXON Neuroscience

Dr. Branislav Kovacech

PRE-EVENT PROGRAMME 4 th MARCH 2024

SITE VISIT TO THE GEDEON RICHTER BIOTECHNOLOGY PLANT IN DEBRECEN

The congress also provides an opportunity to visit the Gedeon Richter Biotechnology plant in Debrecen limited for 40 delegates and available on a first come first serve complimentary basis at 15:00 on 4th March and will last for approximately 2 hours.

Gedeon Richter Plc. embarked on establishing biotechnology development and manufacturing capabilities over a decade ago. As a result, the company today has established sites and teams covering R&D and production activities to enable the creation of a biologics product pipeline in addition to offering CDMO activities in the biopharmaceuticals field.

The company has state-of-the-art manufacturing facilities covering microbial fermentation-based products at its Richter-Helm Biologics sites in the north of Germany, and mammalian cell fermentation-based manufacturing capacities, in addition to fill and finish capabilities at its plants on the Gedeon Richter site in Debrecen, Hungary.

The Debrecen GR site covers production, development, analytical testing and releasing activities on a greenfield site that has expanded continuously over past years, providing a workplace for over 400 highly skilled associates, benefiting from the growth momentum and strong higher education credentials of the city of Debrecen.

Your visit to the Gedeon Richter site will provide you with a good overview of the unique capabilities and assets of the facilities covering manufacturing, development and analytical areas. This will be followed by a site tour including the viewing corridor of the drug substance manufacturing upstream fermentation area and the visit of a laboratory. The tour will finish with a brief outdoor walk around of the site and a wrap-up meeting with refreshments. The 40 participants will be split into 2 groups for the site tour.

TRANSFER: The bus will leave from the front entrance of the Budapest Marriott Hotel on 4th March at 12:00 and will return after the visit at approximately 19:30.

VENDOR PROFILES

5-6 March 2024 |

Fette Compacting GmbH

Grabauer Strasse 24, 21493 Schwarzenbek, Germany

Tel: +49 41 51 120

tablet@fette-compacting.com

www.fette-compacting.com

Fette Compacting is the world’s leading provider of integrated solutions for industrial tablet production, with more than 5,000 machines installed globally. For over 75 years, the company has specialized in high-performance machines for the pharmaceutical, nutraceutical, and chemical industries.

PRODUCT & SERVICE LISTING:

• Processing Machinery & Components: Tableting

• Pharmaceutical Consultancy

• Laboratory & Analytical Technology

• Laboratory Equipment

Firmly at the core of the company is its commitment to improving the quality of life for a growing world population, through innovative product development and services. Collaborative partnerships with customers enable tailored and sustainable developments for the world of tomorrow.

Headquartered in Schwarzenbek, near Hamburg, Germany, Fette Compacting has a second technology and production site in Nanjing, China. The company is the only manufacturer of tablet presses offering a truly global network, with interconnected Competence Centers in Germany, China, the US, India and Brazil. It has an established presence in over 50 countries worldwide.

Fette Compacting is a member of the LMT Group, a family-owned, mid-sized group of companies. The Group also includes LMT Tools, a leading manufacturer of precision tools for industrial processing of construction materials. Globally the Group employs approximately 1,800 people at over 20 locations.

VENDOR PROFILES

5-6 March 2024 | www.pharmconnect.eu

Italvacuum

Via Stroppiana, 3 - 10071 Borgaro Torinese, Italy

Tel: +39 011 470 4651

marketing@italvacuum.com | www.italvacuum.com

Italvacuum is a leading manufacturer of industrial vacuum pumps and vacuum dryers for pharmaceutical, chemical and fine chemicals industries.

Italvacuum’s manufacturing capabilities include a wide range of original and patented products, that comply with the main International Standards (UL, ATEX, ASME and PED) and with FDA and cGMP regulations:

• paddle dryers with eccentric or concentric agitator

• double cone rotary dryers / powders

• tray dryers with extractable or fixed shelves

• laboratory-scale tray dryers

• single stage and double stage vacuum pumps.

Italvacuum also offers a wide range of services:

• Engineering

• Pilot trials

• Customer service.

PRODUCT & SERVICE LISTING:

• Processing Machinery & Components: Pumps, compressors and blowers, Drying, Separation technology

• Laboratory Equipment

Thanks to 85 years of experience, Italvacuum is able to provide turnkey installations and also to realize bespoke equipment and systems, that are built according to customer’s process requirements. The highest levels of quality, safety and productivity in any application, with a special care for sustainability and total respect for the environment.

VENDOR PROFILES

5-6 March 2024 | www.pharmconnect.eu

Hamilton Bonaduz AG

Via Crusch 8, 7402 Bonaduz, Switzerland

Tel: +41 58 610 10 10

contact.pa.ch@hamilton.ch | www.hamiltoncompany.com

Sensor Systems for Bioprocess Monitoring

Hamilton process sensors are well known for high quality, long life, unique features, and competitive pricing. In order to meet these rigorous requirements, we are constantly striving to find new ways to design our sensors. As a result of the extensive work by our research and development department, Hamilton is able to offer outstanding solutions for pH, dissolved oxygen, dissolved carbon dioxide, cell density, conductivity and ORP monitoring.

Tiszatextil

Packaging SAS

8 Rue Decomble, 52000 Chaumont, France

Tel: +33 325 308 000 office_fr@tiszatextil.com | www.tiszatextil.com

TiszaTextil is the renown supplier of pharmaceutical logistic solutions which can replace cost-intensive investments in cleaning and transport systems. For existing transport processes we can also design advanced solutions with our customers. Based on our Minibags and pharmagrade pouches we can bring you astonishingly high ROI figures.

PRODUCT & SERVICE LISTING:

• Process Analytics

• Laboratory & Analytical Technology

• Laboratory Equipment

PRODUCT & SERVICE LISTING:

• Packaging: Plastics

• Packaging Machinery & Equipment: Packaging materials

TiszaTexil wants to contribute to make Health accessible for all humans, so we support the Pharma industry with our cost saving solutions and easy to use and low maintenance products. Besides that TiszaTextil plays also a major role in making the industrial bag business environmentally responsible and economically sustainable. Our single-material Pharma Minibags can be safely incinerated. No harmful chemicals are released, active substances are neutralized and the incineration generates energy. Their one-time use means no washing, so you avoid chemical pollution and save water too.

The safe, economical and eco-friendly transport solution for your pharma company. Go green with TiszaTextil Pharma Minibags!

VENDOR PROFILES

5-6 March 2024 | www.pharmconnect.eu

JBT

ZA en Grain, 39360 MOLINGES, France

Tel: +33 384 414 200

jbtecnics@jbtecnics.com | www.groupejbt.com

EXPERT IN PLASTICS APPLICATIONS FOR THE MEDICAL & PHARMACEUTICAL MARKET

With almost 60 Years of experience in technical plastic parts market, GROUPE JBT can help you gain a strategic advantage by leading your projects in total confidentiality:

• R&D, design & conception of products and medical Devices

• Innovation platform: Patentability, market studies, CE marking

• Design & manufacture of tools (Prototype / multicavities / high productivity)

• Injection moulding in cleanrooms (ISO 7

• Multicomponents injection, Overmoulding

• High tech equipments and robotization

• Laboratory of microbiologic controls

Raumedic AG

Hermann-Staudinger-Str. 2, 95233 Helmbrechts, Germany

Tel: +49 9252 359 0

contact@raumedic.com | www.raumedic.com

As a partner of the international medical technology and pharmaceutical industry, Raumedic develops and produces customized components for customers, including tubing, catheters, and molded parts as well as complex groups of components and systems for a wide range of diagnostic and therapeutic uses. For the clinical areas of neuromonitoring and traumatology, Raumedic produces high-precision pressure-measurement sensors. The company is 100 percent family-owned.

PRODUCT & SERVICE LISTING:

• Custom/ Contract Manufacturing

• Drug Delivery Systems

• Sterile Supplies

• Packaging: Plastics

• Pharmaceutical Consultancy

• OTHERS: Injection Molding in Cleanrooms ISO7, Design and Manufacture of Tools, Assembling

• Assembling (ISO 7 – ISO 8

• Production plants: 4 in France, 1 in Mexico, 1 in Tunisia & 1 in Hungary

• Mechanical workshop in France

• Certifications: ISO 9001, ISO13485, ISO15378, GMP

JBT HUB UP alliance makes your project alive and drives it by providing more skills:

• Connected device, e-plastic…

• LSR, silicone injection/extrusion

• Design and construction of assembly machines, robotized systems, vision and controls.

PRODUCT & SERVICE LISTING:

• Pharmaceuticals Ingredients: Raw materials

• Custom/ Contract Manufacturing

• Process Automation

• Pharmaceutical Consultancy

• Solutions for Biopharmaceuticals & Biologicals

VENDOR PROFILES

5-6 March 2024 | www.pharmconnect.eu

Roche CustomBiotech

Sandhofer Strasse 116, 68305 Mannheim, Germany

Tel: +49 621 759 8580

mannheim.custombiotech@roche.com

www.custombiotech.roche.com

Roche CustomBiotech - We provide reliable, tailormade and high-quality raw materials, kits and technologies to biopharma and diagnostics companies.

PRODUCT & SERVICE LISTING:

• Pharmaceuticals Ingredients: Raw materials, Excipients and fine chemicals

• Solutions for Biopharmaceuticals & Biologicals

• Laboratory & Analytical Technology

• Laboratory Equipment

• OTHERS: Molecular Diagnostics, General Diagnostics

Roche CustomBiotech enables the healthcare industry in bringing state-of-the-art diagnostics and treatments to those in need. With the CustomBiotech division Roche merged its innovative technologies, excellent knowledge, and decades of experience in the Biopharma and Diagnostics Industry. The site in Penzberg, Germany, is Roche ́s powerhouse of manufacturing and its excellence in manufacturing enables companies in Biopharma or Diagnostics to get access to tailored solutions meeting the highest standards in quality, safety and regulatory requirements, from ISO-certified quality management to GMP, animal-free and antibiotic-free production of excipients, raw materials, kits and innovative instruments. The products from Roche CustomBiotech are off the shelf or customizable to meet excellent quality and regulatory needs. Quality, Innovation and the individual customer interest are in the center of the Roche CustomBiotech ́s business, pathing the way for an ever expanding product portfolio meeting the current interests and needs of our customers and thereby enabling innovative drugs and products.

EFA GLOBAL DOCKING

EGD Thermolock - Thermal insulation for indoor ramps and docks. Our solution increases energy efficiency of industrial buildings.

BEFORE AFTER

EFAFLEX - High-speed doors for the pharmaceutical industry.

5-6 March 2024 | www.pharmconnect.eu

EFAFLEX Hungária Ltd.

Hegyalja út 7-13., 1016 Budapest, Hungary

Tel: +36 1 789 5508

info@efaflex.hu | www.efaflex.hu

EFAFLEX – Premium industrial doors from the world market leader

Our high-speed doors for the pharmaceutical sector are certified to ISO Class 5, 6 and 7 (ISO 14644-1) and thus contribute to the lowest possible particle concentration in the air. They therefore offer ideal conditions for the special requirements in the laboratory, in the manufacture of medicines, medical technology or special protective equipment.

EFA GLOBAL DOCKING Ltd.

EFA

GLOBAL DOCKING

Hegyalja út 7-13., 1016

Budapest, Hungary

Tel: +36 1 789 5508

info@efaflex.hu | www.egd.hu

EFA GLOBAL DOCKING – Loading technologies and safety solutions

Thermal bridges at metal docking stations can be eliminated with EGD ThermoLock. We offer a thermal insulation solution to help maintaining constant temperatures, even during loading and unloading of trucks. EGD ThermoLock significantly improves energy efficiency, and greatly reduces exposure to pests, dust or other elements in your buildings.

EFA SERVICES Hungary Ltd.

Sulák utca 2/a., 2030 Érd, Hungary

Tel: +36 1 789 5508

EFASERVICES - Maintenance service for industrial doors and docking systems

• Process Automation

• Clean rooms & Accessories: Clean room construction

• Plant Engineering & Maintenance

• Cold Chain Packing, Storage & Distribution

• Pharmaceutical Storage, Warehousing

By combining information technology and operations, EFASERVICES Ltd. has developed a first-of-itskind, IoT-based predictive industrial door service solution.

YOUR PARTNER IN HEALTHCARE PACKAGING

PLASTRADE Packaging provides a full service of pharmaceutical packaging solutions. With our innovative and highquality products, we contribute to your brand to become more successful.

SOLUTIONS FROM OUR PORTFOLIO INCLUDE:

• spray pumps for nasal, oral, and topical applications (preservative-free and CR solutions)

• plastic closures, droppers, syringes, measuring spoons, and measuring cups

• plastic bottles, jars and vials for liquids, tablets, capsules, and powders

• plastic and aluminum tubes with applicators

• glass bottles, vials, and ampoules

• high barrier blister films, medical films, and liners

• packaging solutions for analysis and diagnostics

• pharmaceutical production lines for filling aseptic and non-aseptic products

5-6 March 2024

PLASTRADE Packaging Kft.

Szépvölgyi út 52., 1025 Budapest, Hungary

Tel: +36 1 886 9225

plastrade@plastrade.hu | www.plastrade.hu

PLASTRADE Packaging is a leading supplier of pharmaceutical packaging materials in Central and Eastern Europe.

PRODUCT & SERVICE LISTING:

• Drug Delivery Systems

• Packaging: Glass, ampoules, vials, tubular; Plastics

• Laboratory Equipment

• Packaging Machinery & Equipment: Machinery and components; Packaging materials

• Distribution

We are proud to supply innovative and high-quality primary packaging solutions for the healthcare market with a product range of:

• spray pumps for nasal, oral and topical applications (CR solutions)

• plastic closures, droppers, syringes, measuring spoons, measuring cups

• plastic bottles, jars and vials for liquids, tablets, capsules and powders

• plastic and aluminium tubes with applicators

• glass bottles, vials and ampoules

• high barrier blister films, medical films and liners

• packaging solutions for analysis and diagnostics

• pharmaceutical production lines for filling aseptic and non-aseptic products

Our extensive expertise, our passion for progress, and focus on collaboration make us your packaging solutions partner of choice.

We constantly strive to deliver high-quality solutions that add value by contributing to enhance brands and engage consumers at the same time.

PRODUCT & SERVICE LISTING:

• Pharmaceutical Consultancy

• IT for the Pharmaceutical Industry

VENDOR PROFILES

5-6 March 2024 |

Vimachem

Pigis Avenue 29, Athens, Greece

Tel: +30 693 284 8129

merfi.zervou@vimachem.com www.vimachem.com

Vimachem’s Optimz Pharma 4.0 platform is a modern manufacturing execution system (MES) developed exclusively for the Pharma / Biotech industries that incorporates AI, IIoT, and Pharma 4.0 principles. The platform enables pharmaceutical and biotech companies to scale faster and with greater flexibility.

Vimachem‘s approach to manufacturing execution systems is fast to deploy and easy to use, with out-ofthe-box connectivity to pre-built Vimachem Pharma 4.0 Intelligence MES apps. The platform also enables easy integration of all machines across pharma production and packaging shop floors. Vimachem‘s deep expertise in pharmaceutical manufacturing operations ensures immediate ROI.

The Vimachem Pharma 4.0 Platform includes several key features, including a multi-tenant cloud platform that enables instant manufacturing analytics and insights from anywhere, digital Batch Records and Logbooks, digital document management (DMS) and guided workflows to support the workforce digitally during critical batch processes. The platform also offers a cutting-edge traceability software platform that enables compliance with global traceability standards while optimizing traceability operations.

PRODUCT & SERVICE LISTING:

• Packaging Machinery & Equipment: Labelling and RFID

WIPOTEC GmbH

Adam-Hoffmann-Straße 26, 67657 Kaiserslautern, Germany

Tel: +49 637 341 460 info@wipotec.com | www.wipotec.com

Wipotec GmbH is a leading provider of cutting-edge weighing and inspection technology headquartered in Kaiserslautern, Germany. With a rich history of innovation and a commitment to precision, Wipotec has established itself as a trusted partner for a diverse range of industries globally.

Wipotec specializes in the design, manufacturing, and distribution of advanced weighing and inspection systems. Key product and service offerings include:

High-Speed Checkweighers: Ensuring accuracy and efficiency in production lines. X-Ray Inspection Systems: Detecting contaminants and ensuring product quality. Serialization and Track & Trace Solutions: Enhancing supply chain visibility and compliance. OEM Integration Services: Collaborative solutions tailored to specific industry requirements.

VENDOR PROFILES

5-6 March 2024 | www.pharmconnect.eu

ZETA GmbH

Zetaplatz 1, 8501 Lieboch, Austria

Tel: +43 3136 9010 1000 office@zeta.com

www.zeta.com/en

As a globally operating end-to-end solution provider for the biopharma industry, ZETA specializes in the design, construction, automation, and qualification of customer-specific systems for aseptic production processes. ZETA offers comprehensive solutions and services along the whole pathway of active substance development and manufacturing. In addition, ZETA serves as an EPCM contractor for major pharmaceutical projects, drives digital innovations, and develops comprehensive decarbonization strategies.

PRODUCT & SERVICE LISTING:

• Processing Machinery & Components: Blending, Mixing

• Process Automation

• Sterile Supplies

• Pharmaceutical Consultancy

• Clean rooms & Accessories: Validation

• Plant Engineering & Maintenance: Modular production facilities

• OTHERS: Sustainable Energy Solutions for Pharma&Biotech, Digital Solutions, Smart Maintenance, Integrated Engineering

PHARMACEUTICALS

Raw mateRials

RAUMEDIC AG

Roche CustomBiotech

excipients and fine chemicals

Roche CustomBiotech

CUSTOM/ CONTRACT MANUFACTURING

JBT

Raumedic AG

DRUG DELIVERY SYSTEMS

JBT

PLASTRADE Packaging

PROCESS AUTOMATION

EFAFLEX Hungária

EFA GLOBAL DOCKING

EFA SERVICES Hungary

Hamilton Bonaduz AG

Raumedic AG

ZETA GmbH

PROCESSING MACHINERY & COMPONENTS

Blending

ZETA GmbH

mixing

ZETA GmbH

PRODUCT LISTING

PHARMACEUTICAL CONSULTANCY

Fette Compacting GmbH

JBT

Raumedic AG

Vimachem

ZETA GmbH

taBleting

Fette Compacting GmbH

pumps, compRessoRs and BloweRs

Italvacuum

dRying

Italvacuum

sepaRation technology

Italvacuum

SOLUTIONS FOR BIOPHARMACEUTICALS & BIOLOGICALS

Raumedic AG

Roche CustomBiotech

LABORATORY & ANALYTICAL TECHNOLOGY

Fette Compacting GmbH

Hamilton Bonaduz AG

Roche CustomBiotech

PACKAGING

glass, ampoules, vials, tuBulaR

PLASTRADE Packaging

plastics

JBT

PLASTRADE Packaging

Tiszatextil Packaging SAS

LABORATORY EQUIPMENT

Fette Compacting GmbH

Hamilton Bonaduz AG

Italvacuum

PLASTRADE Packaging

Roche CustomBiotech

5-6 March 2024

STERILE SUPPLIES

JBT

ZETA GmbH

PACKAGING MACHINERY & EQUIPMENT

machineRy and components

PLASTRADE Packaging

packaging mateRials

PLASTRADE Packaging

Tiszatextil Packaging SAS

laBelling and Rfid

WIPOTEC GmbH

IT FOR THE PHARMACEUTICAL INDUSTRY

Vimachem

DISTRIBUTION

PLASTRADE Packaging

CLEAN ROOMS & ACCESSORIES

validation

ZETA GmbH

clean Room constRuction

EFAFLEX Hungária

EFA GLOBAL DOCKING

EFA SERVICES Hungary

PLANT ENGINEERING & MAINTENANCE

modulaR pRoduction facilities

EFAFLEX Hungária

EFA GLOBAL DOCKING

EFA SERVICES Hungary

ZETA GmbH

OTHERS:

injection molding in cleanRooms iso7; design and manufactuRe of tools; assemBling

JBT

moleculaR diagnostics, geneRal diagnostics

Roche CustomBiotech

sustainaBle eneRgy solutions foR phaRma&Biotech; digital solutions; smaRt maintenance;

integRated engineeRing

ZETA GmbH

CE NTR A L & E AS TER N EURO P E ’ S

LE

19-20 NOVEMBER

CE NTR A L & E AS TER N EURO P E ’ S

LE A D ING B2B N E T W ORK ING EVE N T